Focus Partners Wealth’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Focus Partners Wealth's ATRC Position: Q2 2026 in Review
Focus Partners Wealth increased its AtriCure (ATRC) stake by 26% in Q2 2026, buying an estimated $133K and bringing the position to 22,877 shares worth $640K. The position accounts for ﹤0.01% of the portfolio, ranked #1840.
Focus Partners Wealth first reported a position in ATRC in Q1 2024 and has held it in 9 quarters since. The position peaked at $719K in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Focus Partners Wealth held 22,877 shares of AtriCure worth $640K as of Q2 2026.
- Focus Partners Wealth bought 4,743 AtriCure shares in Q2 2026, an estimated $133K.
- AtriCure made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1840 holding.
- Focus Partners Wealth first reported a position in AtriCure in Q1 2024 and has held it in 9 quarters since.
- Focus Partners Wealth's AtriCure position peaked at $719K in Q4 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.